查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1616781

睡眠呼吸中止症植入物市場機會、成長促進因素、產業趨勢分析與預測 2024 - 2032 年

Sleep Apnea Implants Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年全球睡眠呼吸中止症植入物市場價值為 4.612 億美元，預計 2024-2032 年複合年成長率為 14.8%。該市場的擴張主要是由於阻塞性睡眠呼吸中止症的上升、CPAP 治療依從性的挑戰以及對睡眠呼吸中止症的認知的提高而推動的。全球阻塞性睡眠呼吸中止症 (OSA) 病例激增是睡眠呼吸中止症植入物市場成長的關鍵催化劑。美國國立衛生研究院 (NIH) 的數據表明，全球約有 9.36 億 30-69 歲的成年人受到 OSA 的影響。鑑於 OSA 的廣泛影響，對有效治療解決方案的需求不斷增加。

這項全球挑戰不僅擴大了對治療的需求，也凸顯了睡眠呼吸中止症植入物等創新療法，這些療法有望實現長期管理。整個睡眠呼吸中止症植入物產業根據產品、適應症、最終用途和地區進行分類。睡眠呼吸中止症植入物市場依產品類型分類，腭植入物：舌下神經刺激裝置、橫膈神經刺激器和接骨螺絲系統。 2023年，舌下神經刺激裝置佔88.8%的主導市佔率。

舌下神經刺激裝置在臨床試驗和現實場景中都顯示出令人印象深刻的功效。這使得它們成為中度至重度 OSA 患者的首選，尤其是那些無法耐受持續性呼吸道正壓 (CPAP) 治療的患者。這種有效性鞏固了他們的市場領先地位。根據適應症，睡眠呼吸中止症植入物市場分為中樞性睡眠呼吸中止症和阻塞性睡眠呼吸中止症類別。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 4.612 億美元
預測值 17億美元
複合年成長率 14.8%

阻塞性睡眠呼吸中止症細分市場處於領先地位，2023 年估值為4.32 億美元。低。睡眠呼吸中止症植入物提供了更舒適、更有效的長期替代方案，推動了其在 OSA 領域的應用。 2023 年，北美睡眠呼吸中止症植入物市場估值為 3.583 億美元，預測分析期間複合年成長率為 14.3%。北美是全球睡眠呼吸中止症植入物市場的領導者。

造成這種主導地位的因素包括睡眠呼吸中止症的高盛行率、健全的醫療基礎設施以及對該疾病及其治療方法的日益認知。此外，該地區在採用尖端醫療技術（包括睡眠呼吸中止症植入物）方面的積極立場得到了主要市場參與者的存在、積極的研發努力以及支持性報銷政策的支持。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 阻塞性睡眠呼吸中止症的盛行率不斷增加
      • 對 CPAP 的依從性和依從性較低
      • 技術進步
      • 對睡眠呼吸中止症的認知不斷提高
    • 產業陷阱與挑戰
      • 睡眠呼吸中止症植入物成本高昂
      • 與睡眠呼吸中止症植入物相關的併發症
  • 成長潛力分析
  • 監管環境
  • 報銷版圖
  • 技術景觀
  • 產品管道分析
  • 2023 年定價分析
  • 患者旅程地圖
  • 差距分析
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

  • 主要趨勢
  • 舌下神經刺激裝置
  • 腭植入物
  • 接骨螺絲系統
  • 膈神經刺激器

第 6 章：市場估計與預測：按指標分類，2021 - 2032 年

  • 主要趨勢
  • 中樞性睡眠呼吸中止症
  • 阻塞性睡眠呼吸中止症

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 其他最終用戶

第 8 章：市場估計與預測：按地區分類，2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 瑞士
    • 歐洲其他地區
  • 世界其他地區

第 9 章：公司簡介

  • Asahi Kasei Corporation
  • Inspire Medical System
  • Medtronic plc
  • Nyxoah SA
  • Siesta Medical, Inc.
簡介目錄
Product Code: 5279

The Global Sleep Apnea Implants Market was valued at USD 461.2 million in 2023 and is projected to grow at a CAGR of 14.8% from 2024-2032. The market's expansion is primarily driven by the rising prevalence of obstructive sleep apnea, challenges with compliance to CPAP treatments, and heightened awareness about sleep apnea. The global surge in obstructive sleep apnea (OSA) cases is a key catalyst for the growth of the sleep apnea implant market. Data from the National Institutes of Health (NIH) indicates that around 936 million adults aged 30-69 are globally affected by OSA. Given OSA's widespread impact, there's a mounting demand for effective treatment solutions.

This global challenge is not only amplifying the demand for treatments but also spotlighting innovative therapies like sleep apnea implants, which offer a promise of long-term management. The overall sleep apnea implants industry is classified based on product, indication, end-use, and region. The market for sleep apnea implants is categorized by product types, palatal implants: hypoglossal neurostimulation devices, phrenic nerve stimulators, and bone screw systems. In 2023, hypoglossal neurostimulation devices commanded a dominant market share of 88.8%.

Hypoglossal neurostimulation devices have shown impressive efficacy in both clinical trials and real-world scenarios. This has made them the go-to choice for patients with moderate to severe OSA, especially those who can't tolerate continuous positive airway pressure (CPAP) therapy. Such effectiveness has solidified their leading market position. On the basis of indication, the sleep apnea implants market is divided into central sleep apnea and obstructive sleep apnea categories.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$461.2 Million
Forecast Value$1.7 Billion
CAGR14.8%

The obstructive sleep apnea segment led the market, boasting a valuation of USD 432 million in 2023. While continuous positive airway pressure (CPAP) therapy is the gold standard for treating OSA, many patients find it uncomfortable, resulting in low compliance. Sleep apnea implants present a more comfortable and effective long-term alternative, driving their uptake in the OSA segment. In 2023, the North American sleep apnea implants market was valued at USD 358.3 million, with projections indicating a CAGR of 14.3% during the analysis period. North America stands as the leader in the global sleep apnea implants market.

Factors contributing to this dominance include a high prevalence of sleep apnea, a robust healthcare infrastructure, and an increasing awareness of the condition and its treatments. Moreover, the region's proactive stance in adopting cutting-edge medical technologies, including sleep apnea implants, is bolstered by the presence of major market players, vigorous research and development endeavors, and supportive reimbursement policies.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of obstructive sleep apnea
      • 3.2.1.2 Low compliance & adherence towards CPAP
      • 3.2.1.3 Technological advancements
      • 3.2.1.4 Rising awareness regarding sleep apnea
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High costs of sleep apnea implants
      • 3.2.2.2 Complications associated with sleep apnea implants
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Reimbursement landscape
  • 3.6 Technological landscape
  • 3.7 Product pipeline analysis
  • 3.8 Pricing analysis, 2023
  • 3.9 Patient journey map
  • 3.10 Gap analysis
  • 3.11 Porter's analysis
  • 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn & Units)

  • 5.1 Key trends
  • 5.2 Hypoglossal neurostimulation devices
  • 5.3 Palatal implants
  • 5.4 Bone screw systems
  • 5.5 Phrenic nerve stimulators

Chapter 6 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Central sleep apnea
  • 6.3 Obstructive sleep apnea

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn & Units)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Switzerland
    • 8.3.8 Rest of Europe
  • 8.4 Rest of World

Chapter 9 Company Profiles

  • 9.1 Asahi Kasei Corporation
  • 9.2 Inspire Medical System
  • 9.3 Medtronic plc
  • 9.4 Nyxoah SA
  • 9.5 Siesta Medical, Inc.